Magnetic sieve technology joins the fight against leukaemia
BLOOD DISEASES ARE getting the full attention of MediSieve, a company that has created a magnetic sieve already seeing some success in the fight against malaria. MediSieve’s new technology can use magnetic particles to target problem zones in the blood and could help better treat cancer.
Founder and CEO of MediSieve, Dr George Frodsham, said: “We have always been developing a platform technology to target a wide range of blood-borne diseases. We recently announced our plans to target sepsis and now I’m very excited to share our work against leukaemia, too.”
The magnetic filter, or sieve, that proved so successful at dealing with malaria will soon be tested in medical trials, while the firm’s technicians will turn their attentions to the treatment of other lifethreatening illnesses. MediSieve has brought in an expert on magnetic particles, Dr Cristina Blanco Andujar, to help push things forward.
Dr Blanco said: “I am incredibly passionate about what we’re trying to do here at MediSieve, and I believe that by collaborating with experts in our field we will be able to reach our goals.”
The MediSieve would be used prior to chemotherapy, where it might improve the effectiveness of the drug, and reduce the sometimes punishing side effects. MediSieve expects to have a product ready in 2021.